Publicacións nas que colabora con FERNANDO DOMINGUEZ PUENTE (25)

2022

  1. Silver Clusters of Five Atoms as Highly Selective Antitumoral Agents Through Irreversible Oxidation of Thiols

    Advanced Functional Materials, Vol. 32, Núm. 29

2013

  1. Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: Anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 83, Núm. 3, pp. 330-337

2008

  1. Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers

    Biomacromolecules, Vol. 9, Núm. 8, pp. 2186-2193

  2. Hypochondroplasia and acanthosis nigricans: A new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?

    European Journal of Endocrinology, Vol. 159, Núm. 3, pp. 243-249

  3. Retinoblastoma loss modulates DNA damage response favoring tumor progression

    PLoS ONE, Vol. 3, Núm. 11

2003

  1. Inhibition of Cdk4 activity enhances translation of p27kip1 in quiescent Rb-negative cells

    Journal of Biological Chemistry, Vol. 278, Núm. 15, pp. 12688-12695

  2. TGF-β-induced apoptosis in human thyrocytes is mediated by p27 kip1 reduction and is overridden in neoplastic thyrocytes by NF-κB activation

    Oncogene, Vol. 22, Núm. 49, pp. 7819-7830

1999

  1. Complex regulation of prothymosin alpha in mammary tumors arising in transgenic mice

    Life Sciences, Vol. 64, Núm. 23, pp. 2125-2133

1998

  1. Overexpression of prothymosin α accelerates proliferation and retards differentiation in HL-60 cells

    Biochemical Journal, Vol. 331, Núm. 3, pp. 753-761

  2. Prothymosin α stimulates Ca2+-dependent phosphorylation of elongation factor 2 in cellular extracts

    Journal of Biological Chemistry, Vol. 273, Núm. 17, pp. 10147-10152

  3. TGF-β1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth

    Oncogene, Vol. 16, Núm. 11, pp. 1455-1465

1997

  1. Development of ELISA to estimate thymosin α1, the N terminus of prothymosin α, in human tumors

    Clinical Chemistry, Vol. 43, Núm. 1, pp. 59-63

1996

  1. Evidence for the involvement of non-androgenic testicular factors in the regulation of hypothalamic somatostatin and GHRH mRNA levels

    Molecular Brain Research, Vol. 35, Núm. 1-2, pp. 220-226

1995

  1. Regulation of thymosin β4 mRNA levels during cell proliferation

    Cell Proliferation, Vol. 28, Núm. 2, pp. 85-91

1994

  1. Distribution of prothymosin alpha in rat and human adrenal cortex

    The Anatomical Record, Vol. 239, Núm. 1, pp. 88-94

1993

  1. Effects of free fatty acids on somatostatin secretion, content and mRNA levels in cortical and hypothalamic fetal rat neurones in monolayer culture

    Journal of Molecular Endocrinology, Vol. 10, Núm. 2, pp. 207-214

  2. GHRH Y SU REGULACION

    Endocrinologia, Vol. 40, Núm. 1, pp. 10-14

  3. Prothymosin α mRNA is expressed in competent and proliferating rat thyroid cells (FRTL-4) but is not sufficient to elicit cell progression through the cell cycle

    Journal of Molecular Endocrinology, Vol. 11, Núm. 3, pp. 249-256

  4. Regulation of Somatotroph Cell Proliferation

    Journal of Pediatric Endocrinology and Metabolism, Vol. 6, Núm. 3-4, pp. 245-250

  5. Regulation of prothymosin alpha mRNA levels in rat pituitary tumor cells

    Neuroendocrinology, Vol. 57, Núm. 6, pp. 1048-1056